NO20002481L - Kombinasjonsterapi for behandling av AIDS - Google Patents
Kombinasjonsterapi for behandling av AIDSInfo
- Publication number
- NO20002481L NO20002481L NO20002481A NO20002481A NO20002481L NO 20002481 L NO20002481 L NO 20002481L NO 20002481 A NO20002481 A NO 20002481A NO 20002481 A NO20002481 A NO 20002481A NO 20002481 L NO20002481 L NO 20002481L
- Authority
- NO
- Norway
- Prior art keywords
- combination
- reverse transcriptase
- aids
- inhibitors
- treatment
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title abstract 3
- 238000002648 combination therapy Methods 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 2
- 229940126062 Compound A Drugs 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 108010010369 HIV Protease Proteins 0.000 abstract 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 102100034343 Integrase Human genes 0.000 abstract 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 abstract 1
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6542197P | 1997-11-13 | 1997-11-13 | |
| GBGB9807938.7A GB9807938D0 (en) | 1998-04-15 | 1998-04-15 | Combination therapy for the treatment of AIDS |
| US9094098P | 1998-06-26 | 1998-06-26 | |
| GBGB9819590.2A GB9819590D0 (en) | 1998-09-08 | 1998-09-08 | Combination therapy for the treatment of aids |
| PCT/US1998/024097 WO1999025352A1 (en) | 1997-11-13 | 1998-11-12 | Combination therapy for the treatment of aids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002481D0 NO20002481D0 (no) | 2000-05-12 |
| NO20002481L true NO20002481L (no) | 2000-07-12 |
Family
ID=27451773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002481A NO20002481L (no) | 1997-11-13 | 2000-05-12 | Kombinasjonsterapi for behandling av AIDS |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1044000B1 (sk) |
| JP (1) | JP2001522889A (sk) |
| KR (1) | KR20010032055A (sk) |
| CN (1) | CN1285747A (sk) |
| AR (1) | AR013758A1 (sk) |
| AT (1) | ATE218866T1 (sk) |
| AU (1) | AU749795B2 (sk) |
| BG (1) | BG104507A (sk) |
| BR (1) | BR9814146A (sk) |
| CA (1) | CA2309164A1 (sk) |
| CO (1) | CO4970782A1 (sk) |
| DE (1) | DE69806062T2 (sk) |
| EA (1) | EA200000513A1 (sk) |
| ES (1) | ES2177103T3 (sk) |
| HU (1) | HUP0100365A3 (sk) |
| ID (1) | ID24922A (sk) |
| IL (1) | IL135994A0 (sk) |
| IS (1) | IS5481A (sk) |
| NO (1) | NO20002481L (sk) |
| PE (1) | PE20000020A1 (sk) |
| PL (1) | PL340430A1 (sk) |
| SK (1) | SK6842000A3 (sk) |
| TR (1) | TR200001938T2 (sk) |
| WO (1) | WO1999025352A1 (sk) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| WO2003011221A2 (en) | 2001-07-30 | 2003-02-13 | University Of Southern California | PREPARATION AND USE OF α-KETO PHOSPHONATES |
| AU2004206821C1 (en) | 2003-01-14 | 2009-10-01 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
| GB2400553A (en) * | 2003-04-14 | 2004-10-20 | Cipla Ltd | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
| TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9408305A (pt) * | 1993-12-15 | 1997-08-26 | Merck & Co Inc | Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos |
-
1998
- 1998-11-11 CO CO98066470A patent/CO4970782A1/es unknown
- 1998-11-12 KR KR1020007005176A patent/KR20010032055A/ko not_active Withdrawn
- 1998-11-12 DE DE69806062T patent/DE69806062T2/de not_active Expired - Fee Related
- 1998-11-12 HU HU0100365A patent/HUP0100365A3/hu unknown
- 1998-11-12 CA CA002309164A patent/CA2309164A1/en not_active Abandoned
- 1998-11-12 BR BR9814146-5A patent/BR9814146A/pt not_active Application Discontinuation
- 1998-11-12 AT AT98959424T patent/ATE218866T1/de not_active IP Right Cessation
- 1998-11-12 IL IL13599498A patent/IL135994A0/xx unknown
- 1998-11-12 AU AU15225/99A patent/AU749795B2/en not_active Ceased
- 1998-11-12 TR TR2000/01938T patent/TR200001938T2/xx unknown
- 1998-11-12 PL PL98340430A patent/PL340430A1/xx unknown
- 1998-11-12 WO PCT/US1998/024097 patent/WO1999025352A1/en not_active Ceased
- 1998-11-12 JP JP2000520785A patent/JP2001522889A/ja not_active Withdrawn
- 1998-11-12 CN CN98813077A patent/CN1285747A/zh active Pending
- 1998-11-12 ES ES98959424T patent/ES2177103T3/es not_active Expired - Lifetime
- 1998-11-12 SK SK684-2000A patent/SK6842000A3/sk unknown
- 1998-11-12 ID IDW20000895A patent/ID24922A/id unknown
- 1998-11-12 EA EA200000513A patent/EA200000513A1/ru unknown
- 1998-11-12 PE PE1998001094A patent/PE20000020A1/es not_active Application Discontinuation
- 1998-11-12 AR ARP980105720A patent/AR013758A1/es unknown
- 1998-11-12 EP EP98959424A patent/EP1044000B1/en not_active Expired - Lifetime
-
2000
- 2000-05-09 IS IS5481A patent/IS5481A/is unknown
- 2000-05-12 NO NO20002481A patent/NO20002481L/no not_active Application Discontinuation
- 2000-06-05 BG BG104507A patent/BG104507A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001522889A (ja) | 2001-11-20 |
| BG104507A (bg) | 2001-03-30 |
| TR200001938T2 (tr) | 2001-07-23 |
| PE20000020A1 (es) | 2000-01-27 |
| CO4970782A1 (es) | 2000-11-07 |
| ATE218866T1 (de) | 2002-06-15 |
| HUP0100365A2 (hu) | 2002-05-29 |
| CN1285747A (zh) | 2001-02-28 |
| PL340430A1 (en) | 2001-02-12 |
| HUP0100365A3 (en) | 2002-06-28 |
| CA2309164A1 (en) | 1999-05-27 |
| WO1999025352A1 (en) | 1999-05-27 |
| EP1044000B1 (en) | 2002-06-12 |
| NO20002481D0 (no) | 2000-05-12 |
| IL135994A0 (en) | 2001-05-20 |
| IS5481A (is) | 2000-05-09 |
| AR013758A1 (es) | 2001-01-10 |
| KR20010032055A (ko) | 2001-04-16 |
| BR9814146A (pt) | 2000-10-03 |
| EA200000513A1 (ru) | 2000-10-30 |
| AU1522599A (en) | 1999-06-07 |
| ES2177103T3 (es) | 2002-12-01 |
| SK6842000A3 (en) | 2000-12-11 |
| ID24922A (id) | 2000-08-31 |
| EP1044000A1 (en) | 2000-10-18 |
| AU749795B2 (en) | 2002-07-04 |
| DE69806062D1 (de) | 2002-07-18 |
| DE69806062T2 (de) | 2003-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953308L (no) | Inhibitorer av HIV-reverstranskriptase | |
| DE60036961D1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer | |
| NO954427L (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
| DK1293207T3 (da) | Anvendelse af ritonavir (ABT-538) til forbedring af farmokokinetikken af lægemidler, som metaboliseres af cytochrome P450 i en fremgangsmåde til at behandle AIDS | |
| MXPA04006553A (es) | Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih. | |
| YU53093A (sh) | Benzoksazinoni kao inhibitori hiv reverzne transkriptaze | |
| YU172991A (sh) | Sinergizam inhibitora hiv reverzne transkriptaze | |
| NO953876D0 (no) | HIV-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
| NO962000L (no) | Prolegemidler av en inhibitor av HIV-protease | |
| DE69430385D1 (de) | Hiv-proteaseinhibitoren | |
| NO960775L (no) | Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner | |
| NO20053455L (no) | Anvendelse av en kombinasjon inneholdende en ikke-nukleosid revers transkriptase inhibitor (NNRTI) med en inhibitor av cytokrom P450 sa som protease inhibitorer | |
| NO20002481L (no) | Kombinasjonsterapi for behandling av AIDS | |
| EA199700150A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC | |
| WO2006083553A3 (en) | Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase | |
| NO965591L (no) | Kombinasjonsbehandling av HIV-infeksjon | |
| NO981898D0 (no) | Anvendelse av flupirtin for forhindring og behandling av sykdommer som er forbundet med skade pÕ det hematopotiske cellesystem | |
| NO951608D0 (no) | Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon | |
| DK0774969T3 (da) | HIV-proteaseinhibitor kombination | |
| KR970703770A (ko) | 사람 면역결핍 바이러스 감염에 대한 배합 치료(Combination therapy for HIV infection) | |
| NO944208L (no) | Nye kinazoliner som inhibitorer av HIV-reverstranskriptase | |
| FI970565A0 (fi) | HIV-proteaasia inhiboiva yhdistelmä | |
| AU7076600A (en) | Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase | |
| ECSP982741A (es) | Terapia combinada para el tratamiento del sida | |
| NO931338L (no) | Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |